JPMorgan Chase & Co. 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 08:13 am Purchase | 2025-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | JPMORGAN CHASE & CO JPM | 5,198,084 5.200% | 5,198,084 (New Position) | Filing |